ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >CINACALCET

CINACALCET

CINACALCET Structure
CAS No.
226256-56-0
Chemical Name:
CINACALCET
Synonyms
Sensipar;[(1R)-1-(naphthalen-1-yl)ethyl]({3-[3-(trifluoroMethyl)phenyl]propyl})aMine;AMG 073;Mimpara;Regpara;KRN 1493;Hsdb 7318;Cinacalce;Sinacasse;Sinakasse
CBNumber:
CB5506688
Molecular Formula:
C22H22F3N
Molecular Weight:
357.42
MOL File:
226256-56-0.mol
Modify Date:
2024/4/2 15:24:10

CINACALCET Properties

Boiling point 440.9±45.0 °C(Predicted)
Density 1.154±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Sealed in dry,2-8°C
solubility Chloroform (Slightly), Methanol (Slightly)
form Oil
pka 9.19±0.29(Predicted)
color Yellow
InChI InChI=1/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/s3
InChIKey VDHAWDNDOKGFTD-QEIABERDNA-N
SMILES [C@H](C1=CC=CC2C=CC=CC1=2)(C)NCCCC1C=CC=C(C(F)(F)F)C=1 |&1:0,r|
CAS DataBase Reference 226256-56-0(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

CINACALCET Chemical Properties,Uses,Production

Description

Cinacalcet is the first type II calcimimet ic agent approved that improves CaSR sensi Tivity to calcium . When calcium is bound to the CaSR, phospholipase C is act ivated, and the secretion of PTH is inhibited. In the presence of cinacalcet , not only is a drop in PTH levels observed but also a decrease in serum calcium and phosphorous levels.

Chemical Properties

Yellow Oil

Uses

Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease

Definition

ChEBI: Cinacalcet is a secondary amino compound that is (1R)-1-(naphthalen-1-yl)ethanamine in which one of the hydrogens attached to the nitrogen is substituted by a 3-[3-(trifluoromethyl)phenyl]propyl group. It has a role as a calcimimetic and a P450 inhibitor. It is a member of naphthalenes, a secondary amino compound and a member of (trifluoromethyl)benzenes.

Clinical Use

Cinacalcet hydrochloride is a second-generat ion calcimimetic approved for the treatment of secondary hyperparathyroidism in patients wi th chronic kidney disease on dialysis and for the treatment of hypercalcemia in patients with parathyroid cancer . It can be used alone, with vitamin D, and/or with a phosphate binder .

Side effects

Common side effects of Cinacalcet are nausea, vomiting, dizziness, diarrhoea and loss of appetite.Cinacalcet can cause hypocalcaemia. Patients taking this medication need to be followed closely for common symptoms associated with hypocalcaemia, including tingling, muscle twitching, cramps, mood changes or irritability. On the ECG, there may be a prolonged QT interval. Patients with a history of congenital long QT syndrome, a family history of long QT syndrome, and other conditions predisposing them to prolonged QT intervals may be at increased risk. PTH oversupport can lead to ankylosing bone disease.

CINACALCET Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 192)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Mumbai, India 66 58 Inquiry
J S LABS +91-7330612784 +91-7330612784 Tamil Nadu, India 160 58 Inquiry
Varanous Labs Pvt Ltd +91-7036248882 +91-7036248882 Hyderabad, India 1541 58 Inquiry
Lupin Ltd +91-8019896181 +91-8019896181 Maharashtra, India 93 58 Inquiry
Aarti Industries Limited (AIL) +91-84596144931 +91-9920899935 Maharashtra, India 235 58 Inquiry
Zydus Lifesciences Ltd. +91-0265-2315243 +91-6358895661 Gujarat, India 89 58 Inquiry
Laurus Labs Ltd +91-4066594333 +91-4039804333 Telangana, India 50 58 Inquiry
Vijaya Pharma And Life Science +91-8939866271 +91-8939866271 Tamil Nadu, India 320 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry

Related articles

CINACALCET Spectrum

CINACALCET (aR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine AMG 073 (aR)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine 364782-34-3 (Hydrochloride) Cinacalcet [inn] Hsdb 7318 Unii-uaz6V7728s Cinacalcet base Cinacalcet Discontinued See: C441800 KRN 1493 Mimpara Regpara Cinacelcet HCl (αR)-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl)propyl]-1-napthaleneMethanaMine 10MG/50MG/1KG Cinacalcet(AMG 073) AMG 073 (Cinacalcet) Cinacalcet (R-EnantioMer) Cinacalcet-d3 (R-EnantioMer) 1-NaphthaleneMethanaMine,a-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-,(aR)- Cinacalcet N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine Cinacalcet (Form II ) Cinacalce Sinacasse AMG 073; AMG073; AMG-073 Sinakasse 1-Naphthalenemethanamine, α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, (αR)- Cinacalcet-Reference Standard Cinacalcet Hydrochloride ( (α R) -α -Methyl-N-[3-[3- (trifluoromethyl) phenyl) propyl]-1-napthalenemethanamine Hydrochloride CinacalcetQ: What is Cinacalcet Q: What is the CAS Number of Cinacalcet Q: What is the storage condition of Cinacalcet Sensipar [(1R)-1-(naphthalen-1-yl)ethyl]({3-[3-(trifluoroMethyl)phenyl]propyl})aMine CICALCET-REFERENCE STANDARD N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine 226256-56-0 C22H22F3N Mimpara, Sensipar Intermediates & Fine Chemicals Pharmaceuticals Chiral Reagents